Rxivist logo

Author: Sivan Gazit

  • Most recently observed institution: Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services

Rankings

  • All-time downloads: 1,009,606 (rank: 18 )
  • Categories:
    • epidemiology: 116,235 (rank: 129 (tie) )
    • health policy: 741 (rank: 684 (tie) )
    • infectious diseases: 892,630 (rank: 15 )

Downloads per author, site-wide

Preprints

Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections

infectious diseases more details view paper
  • Downloaded 701,175 times
  • Download rankings, all-time:
    • Site-wide: 3
    • In infectious diseases: 2
  • Year to date:
    • Site-wide: 1
  • Since beginning of last month:
    • Site-wide: 1

Correlation of SARS-CoV-2 Breakthrough Infections to Time-from-vaccine; Preliminary Study

epidemiology more details view paper
  • Downloaded 116,235 times
  • Download rankings, all-time:
    • Site-wide: 44
    • In epidemiology: 9
  • Year to date:
    • Site-wide: 8
  • Since beginning of last month:
    • Site-wide: 25

Decreased SARS-CoV-2 viral load following vaccination

infectious diseases more details view paper
  • Downloaded 87,924 times
  • Download rankings, all-time:
    • Site-wide: 73
    • In infectious diseases: 26
  • Year to date:
    • Site-wide: 17
  • Since beginning of last month:
    • Site-wide: 161

The effectiveness of the first dose of BNT162 b 2 vaccine in reducing SARS-CoV-2 infection 13-24 days after immunization: real-world evidence

infectious diseases more details view paper
  • Downloaded 44,920 times
  • Download rankings, all-time:
    • Site-wide: 168
    • In infectious diseases: 64
  • Year to date:
    • Site-wide: 45
  • Since beginning of last month:
    • Site-wide: 1,279

Short Term Reduction in the Odds of Testing Positive for SARS-CoV-2; a Comparison Between Two Doses and Three doses of the BNT162b2 Vaccine

infectious diseases more details view paper
  • Downloaded 14,826 times
  • Download rankings, all-time:
    • Site-wide: 616
    • In infectious diseases: 219
  • Year to date:
    • Site-wide: 169
  • Since beginning of last month:
    • Site-wide: 20

Associations of the BNT162b2 COVID-19 vaccine effectiveness with patient age and comorbidities at daily resolution

infectious diseases more details view paper
  • Downloaded 11,363 times
  • Download rankings, all-time:
    • Site-wide: 879
    • In infectious diseases: 280
  • Year to date:
    • Site-wide: 229
  • Since beginning of last month:
    • Site-wide: 883

Viral loads of Delta-variant SARS-CoV2 breakthrough infections following vaccination and booster with the BNT162b2 vaccine

infectious diseases more details view paper
  • Downloaded 10,541 times
  • Download rankings, all-time:
    • Site-wide: 981
    • In infectious diseases: 313
  • Year to date:
    • Site-wide: 254
  • Since beginning of last month:
    • Site-wide: 29

SARS-CoV-2 infection risk among unvaccinated is negatively associated with community-level vaccination rates

infectious diseases more details view paper
  • Downloaded 9,363 times
  • Download rankings, all-time:
    • Site-wide: 1,125
    • In infectious diseases: 355
  • Year to date:
    • Site-wide: 298
  • Since beginning of last month:
    • Site-wide: 2,768

Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel

infectious diseases more details view paper
  • Downloaded 7,105 times
  • Download rankings, all-time:
    • Site-wide: 1,582
    • In infectious diseases: 444
  • Year to date:
    • Site-wide: 377
  • Since beginning of last month:
    • Site-wide: 270

A 1 to 1000 SARS-CoV-2 reinfection proportion in members of a large healthcare provider in Israel: a preliminary report

infectious diseases more details view paper
  • Downloaded 2,601 times
  • Download rankings, all-time:
    • Site-wide: 6,403
    • In infectious diseases: 1,100
  • Year to date:
    • Site-wide: 1,175
  • Since beginning of last month:
    • Site-wide: 2,993

Kinetics of SARS-CoV-2 anti-s IgG after BNT162b2 vaccination

infectious diseases more details view paper
  • Downloaded 920 times
  • Download rankings, all-time:
    • Site-wide: 29,676
    • In infectious diseases: 2,457
  • Year to date:
    • Site-wide: 4,824
  • Since beginning of last month:
    • Site-wide: 27,550

BNT162b2 mRNA Vaccine Effectiveness Given Confirmed Exposure; Analysis of Household Members of COVID-19 Patients

infectious diseases more details view paper
  • Downloaded 866 times
  • Download rankings, all-time:
    • Site-wide: 32,383
    • In infectious diseases: 2,569
  • Year to date:
    • Site-wide: 5,262
  • Since beginning of last month:
    • Site-wide: 8,741

Self-reported and physiological reactions to the third BNT162b2 mRNA COVID-19 (booster) vaccine dose

infectious diseases more details view paper
  • Downloaded 851 times
  • Download rankings, all-time:
    • Site-wide: 33,168
    • In infectious diseases: 2,600
  • Year to date:
    • Site-wide: 5,402
  • Since beginning of last month:
    • Site-wide: 370

Survey of Behaviour Attitudes Towards Preventive Measures Following COVID-19 Vaccination

health policy more details view paper
  • Downloaded 741 times
  • Download rankings, all-time:
    • Site-wide: 40,367
    • In health policy: 106
  • Year to date:
    • Site-wide: 6,662
  • Since beginning of last month:
    • Site-wide: 9,075

A Multilayer Model for Early Detection of COVID-19

infectious diseases more details view paper
  • Downloaded 175 times
  • Download rankings, all-time:
    • Site-wide: 137,734
    • In infectious diseases: 5,612
  • Year to date:
    • Site-wide: 49,797
  • Since beginning of last month:
    • Site-wide: 94,954

PanLingua

News